Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07195721) titled 'The Effect of PROSE Treatment on Mental Health' on Sept. 25.
Study Type: Observational
Primary Sponsor: Boston Sight
Condition:
Depression - Major Depressive Disorder
Recruitment Status: Recruiting
Date of First Enrollment: November 11, 2024
Target Sample Size: 200
Countries of Recruitment:
United States
To know more, visit https://clinicaltrials.gov/study/NCT07195721
Published by HT Digital Content Services with permission from Health Daily Digest....